Medtronic PLC (2M6) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medtronic PLC (2M6) has a cash flow conversion efficiency ratio of 0.056x as of January 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.75 Billion ≈ $3.21 Billion USD) by net assets (€49.24 Billion ≈ $57.57 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Medtronic PLC (2M6) balance sheet quality index to measure how much of total assets are equity-financed.
Medtronic PLC - Cash Flow Conversion Efficiency Trend (1990–2025)
This chart illustrates how Medtronic PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 2M6 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Medtronic PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medtronic PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Datadog Inc
NASDAQ:DDOG
|
0.084x |
|
Industrial and Commercial Bank of China Limited
F:ICK
|
0.325x |
|
AXA SA
PA:CS
|
0.131x |
|
Sherwin-Williams Co
NYSE:SHW
|
0.284x |
|
MercadoLibre Inc.
NASDAQ:MELI
|
0.285x |
|
CSX Corporation
NASDAQ:CSX
|
0.094x |
|
Elevance Health Inc
NYSE:ELV
|
0.098x |
|
Glencore plc
MX:GLENN
|
0.089x |
Annual Cash Flow Conversion Efficiency for Medtronic PLC (1990–2025)
The table below shows the annual cash flow conversion efficiency of Medtronic PLC from 1990 to 2025. For the full company profile with market capitalisation and key ratios, see 2M6 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-04-30 | €48.26 Billion ≈ $56.42 Billion |
€7.04 Billion ≈ $8.24 Billion |
0.146x | +8.44% |
| 2024-04-30 | €50.42 Billion ≈ $58.95 Billion |
€6.79 Billion ≈ $7.93 Billion |
0.135x | +15.16% |
| 2023-04-30 | €51.66 Billion ≈ $60.40 Billion |
€6.04 Billion ≈ $7.06 Billion |
0.117x | -16.11% |
| 2022-04-30 | €52.72 Billion ≈ $61.64 Billion |
€7.35 Billion ≈ $8.59 Billion |
0.139x | +15.22% |
| 2021-04-30 | €51.60 Billion ≈ $60.33 Billion |
€6.24 Billion ≈ $7.30 Billion |
0.121x | -14.96% |
| 2020-04-30 | €50.87 Billion ≈ $59.47 Billion |
€7.23 Billion ≈ $8.46 Billion |
0.142x | +1.90% |
| 2019-04-30 | €50.21 Billion ≈ $58.70 Billion |
€7.01 Billion ≈ $8.19 Billion |
0.140x | +51.41% |
| 2018-04-30 | €50.82 Billion ≈ $59.42 Billion |
€4.68 Billion ≈ $5.48 Billion |
0.092x | -32.46% |
| 2017-04-30 | €50.42 Billion ≈ $58.94 Billion |
€6.88 Billion ≈ $8.04 Billion |
0.136x | +35.54% |
| 2016-04-30 | €51.83 Billion ≈ $60.59 Billion |
€5.22 Billion ≈ $6.10 Billion |
0.101x | +9.33% |
| 2015-04-30 | €53.23 Billion ≈ $62.23 Billion |
€4.90 Billion ≈ $5.73 Billion |
0.092x | -63.89% |
| 2014-04-30 | €19.44 Billion ≈ $22.73 Billion |
€4.96 Billion ≈ $5.80 Billion |
0.255x | -2.48% |
| 2013-04-30 | €18.67 Billion ≈ $21.83 Billion |
€4.88 Billion ≈ $5.71 Billion |
0.262x | +2.16% |
| 2012-04-30 | €17.11 Billion ≈ $20.01 Billion |
€4.38 Billion ≈ $5.12 Billion |
0.256x | +9.27% |
| 2011-04-30 | €15.97 Billion ≈ $18.67 Billion |
€3.74 Billion ≈ $4.37 Billion |
0.234x | -17.03% |
| 2010-04-30 | €14.63 Billion ≈ $17.10 Billion |
€4.13 Billion ≈ $4.83 Billion |
0.282x | -6.42% |
| 2009-04-30 | €12.85 Billion ≈ $15.02 Billion |
€3.88 Billion ≈ $4.53 Billion |
0.302x | -0.22% |
| 2008-04-30 | €11.54 Billion ≈ $13.49 Billion |
€3.49 Billion ≈ $4.08 Billion |
0.302x | +11.44% |
| 2007-04-30 | €10.98 Billion ≈ $12.83 Billion |
€2.98 Billion ≈ $3.48 Billion |
0.271x | +15.35% |
| 2006-04-30 | €9.38 Billion ≈ $10.97 Billion |
€2.21 Billion ≈ $2.58 Billion |
0.235x | -12.80% |
| 2005-04-30 | €10.45 Billion ≈ $12.22 Billion |
€2.82 Billion ≈ $3.30 Billion |
0.270x | -13.94% |
| 2004-04-30 | €9.08 Billion ≈ $10.61 Billion |
€2.85 Billion ≈ $3.33 Billion |
0.314x | +19.28% |
| 2003-04-30 | €7.91 Billion ≈ $9.24 Billion |
€2.08 Billion ≈ $2.43 Billion |
0.263x | +6.30% |
| 2002-04-30 | €6.43 Billion ≈ $7.52 Billion |
€1.59 Billion ≈ $1.86 Billion |
0.247x | -25.62% |
| 2001-04-30 | €5.51 Billion ≈ $6.44 Billion |
€1.83 Billion ≈ $2.14 Billion |
0.332x | +43.29% |
| 2000-04-30 | €4.49 Billion ≈ $5.25 Billion |
€1.04 Billion ≈ $1.22 Billion |
0.232x | +86.22% |
| 1999-04-30 | €3.65 Billion ≈ $4.27 Billion |
€455.30 Million ≈ $532.29 Million |
0.125x | -56.84% |
| 1998-04-30 | €2.04 Billion ≈ $2.39 Billion |
€590.10 Million ≈ $689.89 Million |
0.289x | +8.73% |
| 1997-04-30 | €1.75 Billion ≈ $2.04 Billion |
€463.60 Million ≈ $542.00 Million |
0.265x | -5.09% |
| 1996-04-30 | €1.79 Billion ≈ $2.09 Billion |
€500.50 Million ≈ $585.14 Million |
0.280x | -3.56% |
| 1995-04-30 | €1.33 Billion ≈ $1.56 Billion |
€387.20 Million ≈ $452.68 Million |
0.290x | -14.39% |
| 1994-04-30 | €1.05 Billion ≈ $1.23 Billion |
€356.90 Million ≈ $417.25 Million |
0.339x | -2.20% |
| 1993-04-30 | €841.50 Million ≈ $983.80 Million |
€291.50 Million ≈ $340.79 Million |
0.346x | +82.24% |
| 1992-04-30 | €796.50 Million ≈ $931.19 Million |
€151.40 Million ≈ $177.00 Million |
0.190x | +2.58% |
| 1991-04-30 | €683.20 Million ≈ $798.73 Million |
€126.60 Million ≈ $148.01 Million |
0.185x | -6.13% |
| 1990-04-30 | €541.00 Million ≈ $632.49 Million |
€106.80 Million ≈ $124.86 Million |
0.197x | -- |
About Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor sy… Read more